AMMAZZALORSO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 6.307
EU - Europa 4.397
AS - Asia 4.373
SA - Sud America 443
AF - Africa 78
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.607
Nazione #
US - Stati Uniti d'America 6.138
SG - Singapore 1.641
CN - Cina 1.185
IT - Italia 1.027
TR - Turchia 552
IE - Irlanda 538
UA - Ucraina 484
SE - Svezia 466
RU - Federazione Russa 405
VN - Vietnam 400
GB - Regno Unito 387
BR - Brasile 367
FR - Francia 309
IN - India 293
DE - Germania 260
PL - Polonia 142
FI - Finlandia 138
CA - Canada 112
ES - Italia 57
HK - Hong Kong 57
JP - Giappone 46
MX - Messico 37
AT - Austria 34
BD - Bangladesh 31
KR - Corea 31
NL - Olanda 30
CZ - Repubblica Ceca 28
ZA - Sudafrica 28
BE - Belgio 25
AR - Argentina 24
PK - Pakistan 23
LT - Lituania 22
IQ - Iraq 19
ID - Indonesia 14
CL - Cile 13
MA - Marocco 12
VE - Venezuela 12
DZ - Algeria 11
TW - Taiwan 9
EC - Ecuador 8
IL - Israele 8
PT - Portogallo 8
GR - Grecia 7
KE - Kenya 7
PH - Filippine 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CO - Colombia 6
ET - Etiopia 6
HR - Croazia 6
JO - Giordania 6
MY - Malesia 6
CH - Svizzera 5
CR - Costa Rica 5
EG - Egitto 5
IR - Iran 5
JM - Giamaica 5
PE - Perù 5
AL - Albania 4
PY - Paraguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
NP - Nepal 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
YE - Yemen 3
BH - Bahrain 2
EU - Europa 2
HU - Ungheria 2
KH - Cambogia 2
LB - Libano 2
RO - Romania 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
LY - Libia 1
MM - Myanmar 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 15.603
Città #
Singapore 1.257
Chandler 708
San Jose 649
Jacksonville 570
Ashburn 539
Dublin 531
Izmir 343
Beijing 289
Dallas 262
Dearborn 253
Chieti 252
Southend 226
Princeton 215
Nanjing 167
The Dalles 163
Los Angeles 158
Ann Arbor 151
Ho Chi Minh City 133
Santa Clara 128
Wilmington 120
Cambridge 117
Kraków 98
Hanoi 83
New York 82
Nanchang 77
Tongling 68
Altamura 64
Buffalo 56
Woodbridge 56
Houston 50
São Paulo 50
Boardman 49
Munich 49
Hong Kong 47
Moscow 47
Hefei 40
Pescara 40
Hebei 39
Kunming 39
Tokyo 39
Kocaeli 38
Orem 38
Warsaw 38
Council Bluffs 37
Shenyang 36
Tianjin 36
Helsinki 33
Washington 33
Jiaxing 32
Teramo 32
Toronto 32
Redondo Beach 31
Bosa 30
Jinan 29
Atlanta 28
Denver 28
Dong Ket 28
Brooklyn 27
Changsha 27
London 27
Montreal 26
Ottawa 26
Brussels 25
Milan 25
Bologna 23
Poplar 23
Rome 23
Stockholm 23
Vienna 23
Brno 22
Chennai 22
Haiphong 20
Seoul 20
Da Nang 19
Nuremberg 19
Ningbo 18
Norwalk 18
Augusta 17
Chicago 17
Turku 17
Frankfurt am Main 16
Johannesburg 16
Phoenix 16
Amsterdam 15
Ankara 15
Hangzhou 15
Como 14
Seattle 14
Mexico City 13
San Mateo 13
Mumbai 12
Boston 11
Lappeenranta 11
Orange 11
Rio de Janeiro 11
San Vito Chietino 11
Shanghai 11
Auburn Hills 10
Belo Horizonte 10
City of London 10
Totale 9.625
Nome #
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 189
Effects of PPARα inhibition in head and neck paraganglioma cells 189
Anticancer Activity of Stilbene-Based Derivatives 189
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 187
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 186
Synthesis of fibrates analogues and pharmacological evaluation as PPARa agonists 182
Progettazione e sintesi di ossazolidinoni a potenziale attività antibatterica 176
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 176
Sintesi di nuovi derivati dell'anello 2-ossazolidinonico: molecole di notevole interesse come ausiliari chirali e come potenziali agenti antimicrobici 174
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 173
Inhibition of PPARγ by Natural Compounds as a Promising Strategy in Obesity and Diabetes 170
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 168
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 168
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 166
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 165
Asymmetric synthesis of (S)-ibuprofen by esterification with amides of (S)-lactic acid as chiral auxiliaries: experimental and theoretical results 164
2-Substituted Benzothiazoles as Antiproliferative Agents: Novel Insights on Structure-Activity Relationships 163
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 161
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 159
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 158
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 158
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 157
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 156
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 155
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 155
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 154
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 154
Anti-Inflammatory, Antioxidant, and WAT/BAT-Conversion Stimulation Induced by Novel PPAR Ligands: Results from Ex Vivo and In Vitro Studies 153
Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview 153
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 153
Asymmetric synthesis of enantiomerically enriched chiral fibrates, thiols and aminoacids 152
Synthesis and antiplatelet activity of gemfibrozil chiral analogues 151
Sintesi ed attività antibatterica di 3-cinnamoil e 3-piridinilossazolidin -2-oni 149
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 148
Synthesis of diastereomerically enriched 2-bromoesters and their reaction with nucleophiles 148
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 148
Embedding calix[4]resorcinarenes in liposomes: Experimental and computational investigation of the effect of resorcinarene inclusion on liposome properties and stability 147
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 146
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 146
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 145
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 145
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 144
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 143
Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid 142
Antiplatelet activity of gemfibrozil chiral analogues 140
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 140
Synthesis and antiplatelet activity of clofibric acid analogues 139
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 139
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 139
Synthetic Strategies to Serine-Proline Chimeras: An Overview 139
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 136
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 136
N-acylsulfonamides: synthetic routes and biological potential in medicinal chemistry 135
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 134
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 134
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 132
Optically active 2-substituted carboxylic acids isosters of fibrates by 2-bromo esters 131
The anticancer potential of Peroxisome Proliferator-Activated Receptor antagonists 131
Sintesi di analoghi chirali del gemfibrozil 2,5,disostituiti a potenziale attività antiaggregante piastrinica 130
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 129
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 129
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 129
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 128
null 128
Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period 128
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 128
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 127
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 127
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 126
Structural development studies of PPARs ligands based on tyrosine scaffold 126
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 124
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 123
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 123
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 122
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 120
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies 120
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 119
Development of Fibrates as Important Scaffolds in Medicinal Chemistry 119
Effect of milrinone analogues on intracellular calcium increase on single living H9C2 cells 118
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 117
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 117
Synthesis, biological evaluation and molecular modelling of new PPARa agonists 115
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 115
Effects of phosphonate isosters of clofibric acid on the biophysical and pharmacological properties of chloride channels belonging to the CLC superfamily 114
Sintesi asimetrica e determinazione della configurazione assoluta di analoghi chirali solforati del clofibrato 111
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 110
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 110
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 109
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 109
A Review of Strategies for the Development of Alkyl Prolines in Drug Discovery 107
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 107
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 107
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 107
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 106
N-substituted acetamidines as nitric oxide synthase inhibitors 106
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 105
Synthesis and pharmacological evaluation of gemfibrozil chiral analogues as cardiovascular agents 105
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 103
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 102
Methods to Evaluate the Activity of Nitric Oxide Synthase 101
Totale 13.876
Categoria #
all - tutte 57.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021200 0 0 0 0 0 0 0 0 0 108 12 80
2021/2022730 16 13 22 112 59 15 27 61 105 26 90 184
2022/20231.981 145 269 135 202 191 373 92 169 254 24 72 55
2023/2024949 67 35 75 32 61 291 216 13 6 42 8 103
2024/20252.322 87 401 375 61 51 119 88 152 208 124 326 330
2025/20264.913 437 207 489 708 623 312 935 341 517 344 0 0
Totale 16.308